Skip to main content
. 2021 Feb 15;18(1):184–198. doi: 10.20892/j.issn.2095-3941.2020.0012

Figure 3.

Figure 3

Histopathological characterization of patient primary tumors and corresponding xenografts. (A) Representative immunohistochemical staining for TTF1 and P40. (B) Representative hematoxylin and eosin staining and immunohistochemical staining for vimentin, Ki-67, and EGFR of LC-00507. (C) Immunohistochemical staining for PD-L1 of LC-00536 and LC-00781 (400×).